Critically ill children commonly receive coagulant products (plasma and/or platelet
transfusions) to prevent or treat hemorrhage or correct coagulopathy. Unique aspects of …

Most patients on ECMO will develop either a hemorrhagic or thrombotic complication.
Balancing these risks involves careful titration of anticoagulation to prevent clotting and …

CONTEXT Prior criteria to define pediatric multiple organ dysfunction syndrome (MODS) did
not include gastrointestinal dysfunction. OBJECTIVES Our objective was to evaluate current …

Objectives: To present the recommendations and consensus statements with supporting
literature for plasma and platelet transfusions in critically ill neonates and children …

Objective: Although bleeding frequently occurs in critical illness, no published definition to
date describes the severity of bleeding accurately in critically ill children. We sought to …

Objectives: Children supported by extracorporeal membrane oxygenation (ECMO) are at
high risk of bleeding. Though practitioners often prescribe blood components and/or …

Objective: To evaluate the epidemiology of hemostatic transfusions (plasma, platelet, and
cryoprecipitate) in children supported by extracorporeal membrane oxygenation. Design …

Background Most pediatric patients show a decline in platelet counts while on
extracorporeal life support (ECLS) and require multiple platelet transfusions. To better …

Objectives: To describe the use of hemostatic transfusions in children following cardiac
surgery with cardiopulmonary bypass and the association of hemostatic transfusions …

Background Pediatric patients on extracorporeal membrane oxygenation (ECMO) often
receive repeated red blood cell (RBC) transfusions. This study aims to quantify and …